## Background: Bcl-2 protein encoded by the proto-oncogene bcl-2 confers to the cell a survival advantage by inhibiting apoptosis. its aberrant expression has been reported in lymphomas and lung carcinoma. to determine if bcl-2 plays a role in the gastric carcinogenic sequence, the authors studied
Immunohistochemical detection of bcl-2 protein in liver lesions: bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia
β Scribed by M. ZHAO; N-X. ZHANG; M. ECONOMOU; I. BLAHA; J.A. LAISSUE; A. ZIMMERMANN
- Book ID
- 108778529
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 796 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0309-0167
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The aim of this study was to assess the relationship between the expression of the 27βkilodalton (kD) __bcl__β2 protein and survival among nonsmall cell lung carcinoma (NSCLC) patients. ## METHODS Paired tissue samples of histologically confirmed tumor and uninvolved lu
## Background: Bcl-2 and bax genes are known to be involved in the control of apoptotic cell death, an important mechanism of growth regulation that influences the biologic behavior of tumors. the aim of the current study was to investigate the relationship of bcl-2 and bax expression to the rate o
Ninety-four patients with transitional cell carcinoma (TCC) of the renal pelvis and ureter, including dysplastic lesions, were studied for p53 and bcl-2 protein expression by immunohistochemistry. Twenty-one patients were also studied for p53 gene mutations by direct sequencing and for bcl-2 gene re